Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,118 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $956.91 | 67 | $0 (2024) |
| Novo Nordisk Inc | $146.79 | 8 | $0 (2024) |
| Lilly USA, LLC | $126.26 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $111.24 | 8 | $0 (2023) |
| SHIELD THERAPEUTICS INC | $96.01 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $92.34 | 5 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $86.12 | 6 | $0 (2021) |
| Exact Sciences Corporation | $85.32 | 5 | $0 (2024) |
| PFIZER INC. | $80.97 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $79.28 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.63 | 31 | ABBVIE INC. ($223.48) |
| 2023 | $426.42 | 31 | ABBVIE INC. ($222.44) |
| 2022 | $521.39 | 33 | ABBVIE INC. ($214.71) |
| 2021 | $616.84 | 43 | AbbVie Inc. ($296.28) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $53.07 | General |
| Category: Hematology | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 11/06/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $42.94 | General |
| Category: Hematology | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 10/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: PAIN | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 371 | 514 | $73,917 | $25,937 |
| 2022 | 5 | 351 | 556 | $77,286 | $26,786 |
| 2021 | 7 | 408 | 581 | $76,527 | $27,007 |
| 2020 | 12 | 525 | 1,085 | $71,049 | $17,501 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 109 | 109 | $36,654 | $11,175 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 273 | $23,990 | $9,224 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 87 | $12,402 | $4,809 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $696.00 | $682.08 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 21 | $175.00 | $46.20 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 365 | $37,118 | $12,763 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $33,384 | $11,221 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $6,068 | $2,309 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $464.00 | $431.04 | 92.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 22 | 28 | $252.00 | $62.16 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 114 | 114 | $35,568 | $12,254 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 172 | 327 | $33,338 | $11,836 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 27 | $4,626 | $1,386 | 30.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 39 | 48 | $1,824 | $917.10 | 50.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $475.00 | $390.50 | 82.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $444.00 | $187.44 | 42.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 28 | $252.00 | $36.45 | 14.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 158 | 283 | $32,356 | $7,910 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 61 | 61 | $16,562 | $5,706 | 34.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 47 | $7,204 | $2,088 | 29.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 28 | 33 | $1,254 | $503.73 | 40.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 41 | 71 | $3,386 | $335.11 | 9.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 13 | 13 | $273.00 | $249.21 | 91.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $247.00 | $203.06 | 82.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 25 | 27 | $702.00 | $201.61 | 28.7% |
About James Ravencraft, P.A.C
James Ravencraft, P.A.C is a Physician Assistant healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083643274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Ravencraft, P.A.C has received a total of $2,118 in payments from pharmaceutical and medical device companies, with $553.63 received in 2024. These payments were reported across 138 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,118).
As a Medicare-enrolled provider, Ravencraft has provided services to 1,655 Medicare beneficiaries, totaling 2,736 services with total Medicare billing of $97,231. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Ashland, KY
- Active Since 07/01/2006
- Last Updated 05/28/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1083643274
Products in Payments
- VRAYLAR (Drug) $546.26
- UBRELVY (Drug) $388.90
- NURTEC ODT (Drug) $228.22
- XIFAXAN (Drug) $111.24
- ACCRUFER (Drug) $96.01
- Cologuard Collection Kit (Device) $85.32
- TRELEGY ELLIPTA (Drug) $81.09
- TRULICITY (Drug) $66.75
- VOQUEZNA (Drug) $62.01
- MOUNJARO (Drug) $59.51
- Vascepa (Drug) $41.79
- Ozempic (Drug) $39.96
- RYBELSUS (Drug) $34.53
- QULIPTA (Drug) $21.75
- PAXLOVID (Drug) $18.15
- NEXLETOL (Drug) $15.75
- ZORYVE (Drug) $15.50
- GIMOTI (Drug) $15.13
- ENTRESTO (Drug) $15.04
- TRINTELLIX (Drug) $15.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ashland
Sara Everman, Pa-C, PA-C
Physician Assistant — Payments: $9,080
Gregory Moore, Pa-C, PA-C
Physician Assistant — Payments: $4,271
Dustin Adkins, Pa, PA
Physician Assistant — Payments: $3,623
Lindsay Montgomery, Pa-C, PA-C
Physician Assistant — Payments: $3,586
Angela Pannuti, Pa-C, PA-C
Physician Assistant — Payments: $3,068
Deann Brown, Pa-C, Caq-Psych, PA-C, CAQ-PSYCH
Physician Assistant — Payments: $2,989